December 2013 PMID 27942440

C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection.

Fatima Barmania, Michael S Pepper

Download social card

Mentions

12
Peak: 1 in Apr 2022
across 3 sources since Apr 2022

Extended reach

3,719
potential audience

Total likes

12

Video views

1,428

Mentions per month

Apr 2022 – Jan 2025

Where it's discussed

  • News9 articles
  • YouTube2 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

Numerous discussions underscore the potential of CCR5 as a key target, with phrases like 'emerging promising strategy' and 'global accessibility,' which reflect enthusiasm and concern for practical implementation. The tone combines scientific recognition with forward-looking optimism, illustrating a collective belief in its importance for future research and treatment development.

AgreementModerate agreement

Most discussions recognize the importance of targeting CCR5 for HIV control, emphasizing its potential as a promising therapeutic strategy.

InterestHigh interest

Participants show high curiosity about the research, often highlighting its relevance to future HIV treatments.

EngagementModerate engagement

Posts include reflections on the scientific approach and implications, indicating moderate depth of involvement.

ImpactModerate impact

There is a shared view that this research could significantly influence the direction of HIV treatment strategies globally.

Abstract in brief

  • HIV was initially believed to be easier to control with a vaccine, but after about 30 years, no effective vaccine has been developed yet.
  • A significant breakthrough occurred in 2009 when a patient received a bone marrow transplant from a donor with a mutation in the CCR5 gene (CCR5 delta32), leading to the patient becoming HIV-negative.
  • The CCR5 receptor plays a crucial role in HIV immunity, and targeting this receptor is seen as a promising strategy for controlling HIV infection.]

Top posts

Most liked on X and Bluesky
ChiRadio™️©️
@chiradio · X

C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection - PMC ( please make this research and advances available for all #globally) https://t.co/EtcgkNWfYz

Jan 4, 2025 · 2,202 followers View post →

All mentions

Understanding CCR5 and Its Role in HIV Control

This introductory video explains CCR5, a critical receptor in HIV immunity, including its protein expression, significance in infection control, and relevant research. It covers Western blot data and key facts about…

Boster Bio · Apr 20, 2022 1,373 views
ChiRadio™️©️
@chiradio · X

C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection - PMC ( please make this research and advances available for all #globally) https://t.co/EtcgkNWfYz

Jan 4, 2025 · 2,202 followers View post →
Hiv Diagnosis and Treatment Through Advaced Tech | PDF ...
News

doi:10.1016/j.atg.2013.05.004. Understanding the impact of male circumcision interventions on the spread 116. Rottman JB, Ganley KP, Williams K, Wu L, Mackay ...

Dec 13, 2025 View →
Zebra Fish PDF | PDF | Ovary | Puberty
News

silencing complex, PGC= primordial germ cell, ATG= translation start site. ... Ther., doi: 10.1016/j.nephro.2013.05.004. Cho, S.W., Kim, S., Kim, J.M., Kim ...

Dec 13, 2025 View →
Thishifidhfdihfdslkfsfdkfhdfh | PDF | Zygosity | Biology
News

Translational Genomics. 2 (1): 3–16. doi:10.1016/j.atg.2013.05.004. PMC 5133339. PMID 27942440. Rautenbach, ...

Dec 13, 2025 View →
Reel 2021 | PDF | Machine Learning | Biomarker (Medicine)
News

https://doi.org/10.1016/j.atg.2014.09.010. detection techniques for high ... https://doi.org/10.1016/j.nicl.2013.05.004. a comparative study with a ...

Dec 13, 2025 View →
Science Magazine - 08 (August) 02 2013 | PDF | Metabolism ...
News

10.1016/j.tree. 2013.05.004 (2013). 83. E. C. Grimm, J. J. Donovan, K. J. ... sity of Washington, 408 ATG Building, Box 351640, Seattle, WA 98195, USA ...

Dec 13, 2025 View →
MTB Papers Pubmed | PDF | Mycobacterium | Mycobacterium ...
News

DOI: 10.1016/j.tube.2013.05.004. PMCID: PMC3776917 PMID: 23835087 [Indexed for MEDLINE]. 76. J Mol Graph Model. 2012 Sep;38:235-42. doi: 10.1016/j.jmgm.2012.06.

Dec 13, 2025 View →
January 2023 | PDF | Management Of Hiv/Aids | Hiv
News

doi: 10.1016/j. the CCR5 receptor and possibly HIV-related outcomes ... ∆32 in 87 countries based on next-generation. atg.2013.05.004. sequencing of ...

Dec 13, 2025 View →
2020 - Management of Acute Myocarditis and Chronic Inflammatory ...
News

If EGPA: i.v. cyclophosphamide, 600 mg/ ±ATG, 1 mg/kg, usually single- ... doi: 10.1016/j.autrev.2013.05.004 81. Cooper LT Jr, Berry GJ, Shabetai R ...

Dec 13, 2025 View →
Potential of CXCR4 and CCR5 as targets for cancer and HIV therapy
News

doi: 10.1016/j.atg.2013.05.004. PMID: 27942440; PMCID: PMC5133339. Jiao X, Nawab O, Patel T, Kossenkov AV, Halama N, Jaeger D, Pestell RG ...

May 30, 2022 View →